Loading company…
Riskpilot
← Back to search
Sign in
Get full access
FOKUSK AB
AB
Active
Org 5593949471
Kortévägen 1
Medical specialists activities · NACE 8622
Est. 2022
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 3,6M
-7% vs 2024
EBITDA margin
55.6%
-30% vs 2024
Equity ratio
55.5%
Financial strength
Net profit 2024
SEK 876K
-28% vs 2024
EBITDA — year on year
SEK millions
4M
3M
2M
1M
0M
3M
2024
2M
-33%
2024
Key figures
Annual report 2024
Revenue
SEK 3,6M
-7%
EBITDA
SEK 2M
-30%
Net profit
SEK 876K
-28%
Total assets
SEK 3,4M
-19%
Equity
SEK 1,9M
+54%
Employees
1
—
Company information
Legal name
FOKUSK AB
Org number
5593949471
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
2 september 2022
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Ögonläkarvård, ögonplastikkirurgi, allmän läkarvård. Konsultverksamhet inom sjukvård. Skönhet samt hudvård samt estetiska injektionsbehandlingar.
Contact
Address
Kortévägen 1
Email
info@fokusklinik.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Örebro
All Sweden companies
Revenue
SEK millions
0M
1M
2M
3M
5M
4M
2024
4M
2024
EBITDA
SEK millions
0M
1M
2M
3M
3M
3M
2024
2M
2024
Income statement
SEK thousands
Item
2024
2024
Revenue
3 899
3 627
Staff expenses
−39
−709
EBITDA
2 875
2 016
Depreciation & amort.
−709
−576
EBIT
2 165
1 440
Net financials
−135
17
Profit before tax
1 530
1 108
Tax
−316
−231
Net profit
1 214
876
Balance sheet
SEK thousands
Item
2024
2024
Total assets
4 245
3 446
Equity
1 239
1 912
Long-term debt
—
—
Short-term debt
2 506
684
Total debt
2 506
684
Financial ratios
5-year trend
EBITDA margin
55.6%
This company
15.8%
Market median
+252% vs market
2024
2024
Equity ratio
55.5%
This company
38.2%
Market median
+45% vs market
2024
2024
Return on equity
45.8%
This company
18.4%
Market median
+149% vs market
2024
2024
Net profit margin
24.2%
This company
8.1%
Market median
+199% vs market
2024
2024
Asset turnover
1.05×
This company
1.12×
Market median
+6% vs market
2024
2024
Debt / equity
0.80×
This company
0.62×
Market median
+29% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-02-01 – 2024-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2022-09-02 – 2024-01-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
JG
Jens Gunnar Forneng
Chief Auditor
Chief Auditor
2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
IC
Iman Chatila
Deputy Board Member
2022
HN
Hani Naser Chatila
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of FOKUSK AB also hold positions in
0
other companies.
Person
Role here
Other companies
Jens Gunnar Forneng
Chief Auditor
0 companies
Iman Chatila
Deputy Board Member
0 companies
Hani Naser Chatila
Board of Directors
0 companies